January 29, 2015 4:46 AM ET


Company Overview of Blue Ash Therapeutics, LLC

Company Overview

Blue Ash Therapeutics, LLC develops Azimilide, an oral once-daily cardiac antiarrhythmic drug. The company was founded in 2008 and is based in Cincinnati, Ohio. As of April 19, 2011, Blue Ash Therapeutics, LLC operates as a subsidiary of Forest Laboratories Holdings Limited.

4555 Lake Forest Drive

Suite 194

Cincinnati, OH 45242

United States

Founded in 2008



Key Executives for Blue Ash Therapeutics, LLC

Age: 58
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Serenity Pharmaceuticals, LLC United States
Nanotope, Inc. United States
Dechra Veterinary Products, LLC United States
Amarin Pharmaceuticals, Inc. United States
T3D Therapeutics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Blue Ash Therapeutics, LLC, please visit www.blueashtx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.